Biogen Inc. (0R1B.L) LSE

Currency In USD

Key Executives

Name	Title	Pay	Year Born
Christopher A. Viehbacher	President, Chief Executive Officer & Director	5.28M	1961
Rachid Izzar	Executive Vice President and Head of Global Product Strategy & Commercialization	1.27M	1975
Ginger Gregory	Executive Vice President & Chief Human Resources Officer	1.59M	1968
Robin C. Kramer	Executive Vice President & Chief Financial Officer	1.63M	1966
Priya Singhal	Executive Vice President & Head of Development	2.01M	1968
Nicole Murphy	Executive Vice President and Head of Pharmaceutical Operations & Technology	2.01M	1973
Susan H. Alexander	Executive Vice President & Chief Legal Officer	2.25M	1957
Wolfram Schmidt	President & Head of Europe	0	N/A
Sean Godbout	VP, Chief Accounting Officer & Global Corporate Controller	0	1974
Alisha A. Alaimo	President & Head of North America	0	N/A
Guy Hadari	Chief Information Officer	0	N/A
Adam Keeney	Executive Vice President & Head of Corporate Development	0	1977
Natacha Gassenbach	Chief Communication Officer & Head of Corporate Affairs	0	N/A
Tim Power	Head of Investor Relations	0	N/A
Fraser Hall	President & Head of Intercontinental Region	0	N/A

Name

Title

Pay

Year Born

Christopher A. Viehbacher

President, Chief Executive Officer & Director

5.28M

1961

Rachid Izzar

Executive Vice President and Head of Global Product Strategy & Commercialization

1.27M

1975

Ginger Gregory

Executive Vice President & Chief Human Resources Officer

1.59M

1968

Robin C. Kramer

Executive Vice President & Chief Financial Officer

1.63M

1966

Priya Singhal

Executive Vice President & Head of Development

2.01M

1968

Nicole Murphy

Executive Vice President and Head of Pharmaceutical Operations & Technology

2.01M

1973

Susan H. Alexander

Executive Vice President & Chief Legal Officer

2.25M

1957

Wolfram Schmidt

President & Head of Europe

N/A

Sean Godbout

VP, Chief Accounting Officer & Global Corporate Controller

1974

Alisha A. Alaimo

President & Head of North America

N/A

Guy Hadari

Chief Information Officer

N/A

Adam Keeney

Executive Vice President & Head of Corporate Development

1977

Natacha Gassenbach

Chief Communication Officer & Head of Corporate Affairs

N/A

Tim Power

Head of Investor Relations

N/A

Fraser Hall

President & Head of Intercontinental Region

N/A

Description

Biogen Inc. is a biopharmaceutical firm dedicated to the discovery, advancement, and provision of treatments for conditions affecting the nervous system. Headquartered in Cambridge, Massachusetts, the company employs 7,800 full-time staff. Its primary focus involves the research, development, production, and distribution of therapies targeting a range of severe neurological, rare, and autoimmune disorders. Among its commercialized pharmaceutical offerings are medications such as TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA, all prescribed for multiple sclerosis (MS). Additionally, Biogen provides FUMADERM for severe plaque psoriasis and SPINRAZA for individuals with spinal muscular atrophy (SMA). Biogen also maintains a strategic alliance with Genentech, Inc., a member of the Roche Group. This partnership covers products like RITUXAN, utilized for conditions such as non-Hodgkin's lymphoma and chronic lymphocytic leukemia (CLL), and GAZYVA, indicated for CLL and follicular lymphoma, alongside other anti-CD20-based treatments. The company's development pipeline features numerous experimental therapies, including OCREVUS, Biosimilar adalimumab, Aducanumab, E2609, BIIB074, BAN2401, Opicinumab, CIRARA, BIIB061, BIIB054, BIIB067, and BIIB068.